why is it so important to know if you have braf-v600e?
Published 3 years ago • 1.8K plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:49
what is a braf-v600e mutation?
-
3:03
what is the importance of combination therapies for braf?
-
6:01
how to know when a re-biopsy is necessary for an advanced nsclc patient?
-
7:40
treatment options for braf v600e mnsclc
-
2:45
ulixertinib in tumors with braf fusions, non-v600e or non-v600k braf mutations
-
5:25
are all ild cases ipf?
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
1:10:25
mark lupo - individualized care for thyroid nodules and cancer
-
1:35:47
braf-mutated mcrc: from diagnosis to treatment
-
2:31
alterations in the braf gene that may affect treatment and survival response in adult brain cancers
-
5:41
understanding nsclc treatments for less common mutations: alk, braf, ros1, her2, met
-
12:42
no one knows what causes pulmonary fibrosis?
-
3:33
what is ‘comprehensive biomarker testing’ and why is it important in lung cancer?
-
18:36
breakdown of braf testing and implications
-
7:32
continuous vs intermittent dosing of dabrafenib and trametinib in braf mutated melanoma
-
4:08
targeted therapies in lung cancer
-
4:58
progression of braf v600e metastatic nsclc
-
45:12
novel treatments and clinical trials for low grade gliomas
-
1:31:21
lung cancer precision medicine summit
-
58:18
braf v600e status effect on lymph node-metastasis-associated mortality in ptc with dr. linwah yip
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
3:43
understanding the braf-mutated population in nsclc